Urolithin A Attenuates Hyperuricemic Nephropathy in Fructose-Fed Mice by Impairing STING-NLRP3 Axis-Mediated Inflammatory Response via Restoration of Parkin-Dependent Mitophagy
Urolithin A (UroA) is one of the primary intestinal metabolites of ellagitannins, showing translational potential as a nutritional intervention in humans. Mounting evidence suggests that fructose consumption contributes to the progression of chronic kidney disease (CKD) that manifests in hyperuricem...
Main Authors: | Cong Zhang, Yingying Song, Liang Chen, Peng Chen, Ming Yuan, Yan Meng, Qi Wang, Guohua Zheng, Zhenpeng Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.907209/full |
Similar Items
-
Progress on the role of NLRP3 inflammasome in hyperuricemic nephropathy
by: DAI Zhixin, WANG Yumin
Published: (2023-02-01) -
Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
by: Dona Pamoda W. Jayatunga, et al.
Published: (2021-10-01) -
Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation
by: Guangxing Shui, et al.
Published: (2022-10-01) -
Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice
by: Guozheng Li, et al.
Published: (2020-10-01) -
Urolithin A Protects Chondrocytes From Mechanical Overloading-Induced Injuries
by: Yuchen He, et al.
Published: (2021-06-01)